Independently Tested Each batch is independently tested to ensure product purity and dosage
Type 2 diabetes can be challenging enough to manage without the added risk of chronic kidney disease, and I have seen in my own practice that patients with type 2 diabetes and chronic kidney disease need extra support from medications that may have a profound clinical impact by lowering the risk of major kidney and cardiovascular outcomes, said Richard E Pratley (AdventHealth Diabetes Institute, Orlando, USA) co-chair of the FLOW trial
H Tr Ln Da Sng u Mu T Bn Trong y l tc dng c quan tm rng ri, c bit trong lnh vc lm p
Get safe, personalised advice to keep your treatment on track
Semaglutide is a GLP-1 receptor agonist, while tirzepatide targets both GLP-1 and GIP receptors, which may provide additional appetite control and metabolic support depending on the patient
However, no human studies have examined truly long-term use extending over years or decades